Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Liraglutide RD12014 vs Victoza in Healthy Volunteers
NCT05294536Phase 1Completed
- Sponsor
- Sunshine Lake Pharma
- Start
- Jun 2020
- Primary completion
- Jul 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of liraglutide in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Sunshine Lake Pharma. Primary endpoints: Maximum plasma drug concentration and Area under the plasma concentration-time curve from time zero to time t. Started Jun 2020; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05294536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05294536.